Skip to main content
. 2020 Jul 17;10:1034. doi: 10.3389/fonc.2020.01034

Figure 3.

Figure 3

miR-125b-5p is negatively associated with colon cancer and cisplatin resistance. (A) Quantitative RT-PCR results of the miR-125b-5p expressions in 35 normal colon tissues and 35 tumor tissues (B) Quantitative RT-PCR results of the miR-125b-5p expressions in normal colon epithelial cell and five colon cancer cells. (C) Expressions of miR-125b-5p were detected from SW480 parental and cisplatin-resistant cells by qRT-PCT. (D) Cisplatin-resistant SW480 cells were transfected with control miR or miR-125b-5p, followed by cisplatin treatments at the indicated concentrations. Cell viability was measured by MTT assay. Data are presented as mean ± SD. *p < 0.05, **p < 0.01, and ***p < 0.001.